Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-21-020437

Director acquired 11,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gallagher Carol Giltner Director 2021-06-08 Grant or award +11,000 111,818 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Gallagher Carol Giltner Director 2021-06-08 Grant or award · Non-Qualified Stock Option (Right to Buy) +17,500 17,500 D: show line 2 in the form
Loading xslF345X03/form4.xml…